IP Library Granted Patent US 12,370,310
Granted Patent B2
US 12,370,310 · App. 18/960,071 · Granted Jul 29, 2025

Medicament container carrier and adapter

Inventors: Derek Fenlon (Wexford, IE); Pascal Launois (Dublin, IE); Julian McDonnell (County Wicklow, IE); Martina Moyne (County Donegal, IE); Conor Mulcahy (County Dublin, IE)
Assignee: Sanofi-Aventis Deutschland GMBH
A61M5/19A61J1/2096A61M5/3129A61J1/201
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,370,310
App. No.
18/960,071
Granted
Jul 29, 2025
Kind
B2
Abstract

Described is a medicament container carrier adapted to hold a first medicament container having a first predetermined size and capable of containing more than a first volume of a medicament. The container carrier comprises a body, and an adapter coupled to the body. The adapter is adapted to hold a second medicament container having a second predetermined size different from the first predetermined size and capable of containing no more than the first volume of the medicament.

Claims (50)

1. An auto-injector comprising:

a syringe carrier;

a syringe comprising a barrel that extends from a distal needle of the syringe to a proximal flange of the syringe, the barrel defining an opening for a volume of a medicament; and

a translucent syringe support disposed in the syringe carrier, the translucent syringe support comprising:

one or more first abutment surfaces engaged to diametrically opposite portions of a proximal side of the proximal flange of the syringe to limit proximal movement of the syringe relative to the translucent syringe support;

a second abutment surface in sliding engagement to an inner surface of the syringe carrier; and

a third abutment surface that is distal to a distal side of the proximal flange of the syringe to limit distal movement of the syringe relative to the translucent syringe support,

wherein the auto-injector is configured to dispense the volume of the medicament through the distal needle of the syringe by distally moving a stopper within the barrel of the syringe.

2. The auto-injector of claim 1 , wherein the volume of the medicament is greater than 0 milliliters and less than 2 milliliters.

3. The auto-injector of claim 1 , wherein the translucent syringe support comprises a pair of fourth abutment surfaces configured to limit a rotation of the syringe relative to the syringe carrier, the pair of fourth abutment surfaces facing one another and being perpendicular to the one or more first abutment surfaces.

4. The auto-injector of claim 3 , wherein the pair of fourth abutment surfaces of the translucent syringe support are in direct contact to the syringe.

5. The auto-injector of claim 1 , wherein the third abutment surface of the translucent syringe support is in direct contact to the syringe.

6. The auto-injector of claim 1 , wherein the distal side of the proximal flange of the syringe is proximally spaced from the translucent syringe support.

7. The auto-injector of claim 1 , wherein the translucent syringe support comprises an axially-extending portion located radially outward of the proximal flange of the syringe, the axially-extending portion extending from the distal side of the proximal flange of the syringe to the proximal side of the proximal flange of the syringe.

8. The auto-injector of claim 7 , wherein the translucent syringe support comprises a proximal portion extending radially inward from a proximal end of the axially-extending portion on the proximal side of the proximal flange, the proximal portion defining the one or more first abutment surfaces.

9. The auto-injector of claim 8 , wherein the one or more first abutment surfaces extend in a plane that is perpendicular to a longitudinal axis of the syringe along a substantial entirety of the one or more first abutment surfaces.

10. An auto-injector comprising:

a syringe carrier; and

a translucent syringe support configured to be disposed in the syringe carrier, the translucent syringe support comprising:

one or more first abutment surfaces configured to engage diametrically opposite portions of a proximal side of a proximal flange of a syringe to limit proximal movement of the syringe relative to the translucent syringe support when the proximal flange of the syringe is disposed in the translucent syringe support;

a second abutment surface configured to slidably engage an inner surface of the syringe carrier when the translucent syringe support is disposed in the syringe carrier; and

a third abutment surface that is distal to a distal side of the proximal flange of the syringe to limit distal movement of the syringe relative to the translucent syringe support when the proximal flange of the syringe is disposed in the translucent syringe support.

11. The auto-injector of claim 10 , wherein the translucent syringe support comprises a pair of fourth abutment surfaces configured to limit a rotation of the syringe relative to the syringe carrier when the proximal flange of the syringe is disposed in the translucent syringe support.

12. The auto-injector of claim 11 , wherein the pair of fourth abutment surfaces face one another.

13. The auto-injector of claim 11 , wherein the pair of fourth abutment surfaces are perpendicular to the one or more first abutment surfaces.

14. The auto-injector of claim 11 , wherein the pair of fourth abutment surfaces of the translucent syringe support are configured to directly contact the syringe when the proximal flange of the syringe is disposed in the translucent syringe support.

15. The auto-injector of claim 10 , wherein the auto-injector is configured such that a distal needle of the syringe is distal to a distal end of the syringe carrier when the proximal flange of the syringe is disposed in the translucent syringe support and the translucent syringe support is disposed in the syringe carrier.

16. The auto-injector of claim 15 , wherein the auto-injector is configured such that a proximal end of the translucent syringe support is proximal to a proximal end of the syringe carrier when the translucent syringe support is disposed in the syringe carrier.

17. The auto-injector of claim 10 , comprising the syringe, the syringe containing a volume of a medicament greater than 0 milliliters and less than 2 milliliters.

18. The auto-injector of claim 17 , wherein the proximal flange of the syringe comprises one or more circular portions.

19. An auto-injector comprising:

a housing;

a syringe carrier disposed in the housing; and

a translucent syringe support disposed in the syringe carrier, the translucent syringe support comprising:

a first abutment surface configured to engage a proximal side of a proximal flange of a syringe to limit proximal movement of the syringe relative to the translucent syringe support when the proximal flange of the syringe is disposed in the translucent syringe support; and

a second abutment surface engaged to an inner surface of the syringe carrier, the second abutment surface being radially outward of the first abutment surface and extending in a direction substantially perpendicular to the first abutment surface.

20. The auto-injector of claim 19 , wherein the translucent syringe support is configured to limit distal movement of the syringe relative to the translucent syringe support when the proximal flange of the syringe is disposed in the translucent syringe support with the proximal side of the proximal flange engaged to the first abutment surface of the translucent syringe support.

21. The auto-injector of claim 20 , wherein the translucent syringe support and the syringe are configured such that a distal side of the proximal flange is proximally spaced from the translucent syringe support when the proximal flange of the syringe is disposed in the translucent syringe support with the proximal side of the proximal flange engaged to the first abutment surface of the translucent syringe support.

22. The auto-injector of claim 20 , wherein the translucent syringe support is configured such that a proximal portion of the translucent syringe support at least partially surrounds diametrically opposite sides of the proximal flange of the syringe when the proximal flange of the syringe is disposed in the translucent syringe support with the proximal side of the proximal flange engaged to the first abutment surface of the translucent syringe support.

23. The auto-injector of claim 19 , comprising the syringe disposed in the translucent syringe support, the syringe containing a volume of a medicament greater than 0 milliliters and less than 2 milliliters.

24. A translucent syringe support for a syringe, the translucent syringe support comprising:

one or more first abutment surfaces configured to engage diametrically opposite portions of a proximal side of a proximal flange of the syringe to limit proximal movement of the syringe relative to the translucent syringe support when the syringe is disposed in the translucent syringe support;

a second abutment surface configured to slidably engage an inner surface of a syringe carrier of an auto-injector for moving the syringe carrier and the syringe within the auto-injector; and

a third abutment surface that is distal to a distal side of the proximal flange of the syringe to limit distal movement of the syringe relative to the translucent syringe support when the syringe is disposed in the translucent syringe support.

25. The translucent syringe support of claim 24 , comprising an axially-extending portion configured to be radially outward of the proximal flange of the syringe and extending from the distal side of the proximal flange of the syringe to the proximal side of the proximal flange of the syringe when the syringe is disposed in the translucent syringe support.

26. The translucent syringe support of claim 25 , comprising a proximal portion extending radially inward from a proximal end of the axially-extending portion on the proximal side of the proximal flange, a distal side of the proximal portion defining the one or more first abutment surfaces.

27. The translucent syringe support of claim 26 , wherein a substantial entirety of the one or more first abutment surfaces extend in a plane that is perpendicular to a longitudinal axis of the syringe.

28. The translucent syringe support of claim 24 , wherein the translucent syringe support comprises a pair of fourth abutment surfaces configured to limit a rotation of the syringe relative to the syringe carrier when the syringe is disposed in the translucent syringe support.

29. The translucent syringe support of claim 28 , wherein the pair of fourth abutment surfaces face one another and are perpendicular to the one or more first abutment surfaces.

30. The translucent syringe support of claim 24 , wherein the distal side of the proximal flange of the syringe is proximally spaced from the translucent syringe support when the syringe is disposed in the translucent syringe support with the proximal side of the proximal flange of the syringe engaged to the one or more first abutment surfaces.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 1, 2024
From: FENLON, DEREK; LAUNOIS, PASCAL; MCDONNELL, JULIAN; MOYNE, MARTINA; MULCAHY, CONOR
To: SANOFI-AVENTIS DEUTSCHLAND GMBH
Reel/Frame 069441/0725 →
Priority Claims (1)
EP 13159253 · Mar 14, 2013 · regional
Continuity (3)
Continuation 17564354 · Dec 29, 2021
Continuation 14775316
Related Publication 20250082854A1 · Mar 13, 2025
References Cited (298)
US 3026873A · Miskel et al. · 1962 [cited by applicant]
US 3076455A · McConnaughey et al. · 1963 [cited by applicant]
US 3144178A · Sarnoff · 1964 [cited by applicant]
US 3880163A · Ritterskamp · 1975 [cited by applicant]
US 4563175A · Lafond · 1986 [cited by applicant]
US 4643724A · Jobe · 1987 [cited by applicant]
US 4655751A · Harbaugh · 1987 [cited by applicant]
US 4664653A · Sagstetter et al. · 1987 [cited by applicant]
US 4735311A · Lowe et al. · 1988 [cited by applicant]
US 4838857A · Strowe et al. · 1989 [cited by applicant]
US 4871355A · Kikkawa · 1989 [cited by applicant]
US 4909791A · Norelli · 1990 [cited by applicant]
US 4931040A · Haber et al. · 1990 [cited by applicant]
US 4946447A · Hardcastle et al. · 1990 [cited by applicant]
US 4964866A · Szwarc · 1990 [cited by applicant]
US 4973318A · Holm et al. · 1990 [cited by applicant]
US 4990142A · Hoffman et al. · 1991 [cited by applicant]
US 4997422A · Chow et al. · 1991 [cited by applicant]
US 5000744A · Hoffman et al. · 1991 [cited by applicant]
US 5078698A · Stiehl et al. · 1992 [cited by applicant]
US 5085641A · Sarnoff et al. · 1992 [cited by applicant]
US 5163918A · Righi et al. · 1992 [cited by applicant]
US 5169392A · Ranford et al. · 1992 [cited by applicant]
US 5281198A · Haber et al. · 1994 [cited by applicant]
US 5282793A · Larson · 1994 [cited by applicant]
US 5290255A · Vallelunga et al. · 1994 [cited by applicant]
US 5320609A · Haber et al. · 1994 [cited by applicant]
US 5322511A · Armbruster et al. · 1994 [cited by applicant]
US 5344407A · Ryan · 1994 [cited by applicant]
US 5350367A · Stiehl et al. · 1994 [cited by applicant]
US 5356395A · Chen · 1994 [cited by applicant]
US 5368578A · Covington et al. · 1994 [cited by applicant]
US 5383858A · Reilly et al. · 1995 [cited by applicant]
US 5383863A · Mardones · 1995 [cited by applicant]
US 5439450A · Haedt · 1995 [cited by applicant]
US 5451214A · Hajishoreh · 1995 [cited by applicant]
US 5480387A · Gabriel et al. · 1996 [cited by applicant]
US 5520653A · Reilly et al. · 1996 [cited by applicant]
US 5599309A · Marshall et al. · 1997 [cited by applicant]
US 5637101A · Shillington · 1997 [cited by applicant]
US 5709662A · Olive et al. · 1998 [cited by applicant]
US 5779675A · Uber et al. · 1998 [cited by applicant]
US 5865805A · Ziemba · 1999 [cited by applicant]
US 5913844A · Fago et al. · 1999 [cited by applicant]
US 5925032A · Clements · 1999 [cited by applicant]
US 5928205A · Marshall · 1999 [cited by applicant]
US 5928698A · Soyad · 1999 [cited by applicant]
US 6059756A · Yeh · 2000 [cited by applicant]
US 6090082A · King et al. · 2000 [cited by applicant]
US 6203530B1 · Stewart · 2001 [cited by applicant]
US 6210369B1 · Wilmot et al. · 2001 [cited by applicant]
US 6371939B2 · Bergens et al. · 2002 [cited by applicant]
US 6409701B1 · Cohn et al. · 2002 [cited by applicant]
US 6454743B1 · Weber · 2002 [cited by applicant]
US 6544234B1 · Gabriel · 2003 [cited by applicant]
US 6613022B1 · Doyle · 2003 [cited by applicant]
US 6656163B1 · Marshall et al. · 2003 [cited by applicant]
US 6726657B1 · Dedig et al. · 2004 [cited by applicant]
US 6743205B2 · Nolan, Jr. et al. · 2004 [cited by applicant]
US 7118552B2 · Shaw et al. · 2006 [cited by applicant]
US 7288078B2 · Fitzgerald · 2007 [cited by applicant]
US 7449012B2 · Young et al. · 2008 [cited by applicant]
US 7597685B2 · Olson · 2009 [cited by applicant]
US 7717877B2 · Lavi et al. · 2010 [cited by applicant]
US 7918824B2 · Bishop et al. · 2011 [cited by applicant]
US 7955303B2 · Burren et al. · 2011 [cited by applicant]
US 8409138B2 · James et al. · 2013 [cited by applicant]
US 8647299B2 · Stamp · 2014 [cited by applicant]
US 8734394B2 · Admas et al. · 2014 [cited by applicant]
US 8845594B2 · Jennings · 2014 [cited by applicant]
US 8876785B2 · Holmqvist · 2014 [cited by applicant]
US 8900197B2 · Crow · 2014 [cited by applicant]
US 8992746B2 · Miyaji et al. · 2015 [cited by applicant]
US 9044553B2 · James et al. · 2015 [cited by applicant]
US 9072833B2 · Jennings et al. · 2015 [cited by applicant]
US 9180259B2 · Lesch, Jr. · 2015 [cited by applicant]
US 9216256B2 · Olson et al. · 2015 [cited by applicant]
US 9233213B2 · Olson et al. · 2016 [cited by applicant]
US 9242053B2 · Wozencroft · 2016 [cited by applicant]
US 9289554B2 · Hourmand et al. · 2016 [cited by applicant]
US 9402957B2 · Adams et al. · 2016 [cited by applicant]
US 9408970B2 · Hourmand et al. · 2016 [cited by applicant]
US 9408976B2 · Olson et al. · 2016 [cited by applicant]
US 9713678B2 · Hourmand et al. · 2017 [cited by applicant]
US 9757520B2 · Corrigan · 2017 [cited by applicant]
US 9867940B2 · Holmqvist et al. · 2018 [cited by applicant]
US 9872961B2 · Fourt et al. · 2018 [cited by applicant]
US 10118001B2 · Fourt et al. · 2018 [cited by applicant]
US 10314981B2 · Sampson et al. · 2019 [cited by applicant]
US 10350362B2 · Dennis, Jr. et al. · 2019 [cited by applicant]
US 10363377B2 · Atterbury et al. · 2019 [cited by applicant]
US 10420898B2 · Daniel · 2019 [cited by applicant]
US 10434258B2 · Hourmand et al. · 2019 [cited by applicant]
US 10441719B2 · Hourman et al. · 2019 [cited by applicant]
US 10569019B2 · Hirschel et al. · 2020 [cited by applicant]
US 10646656B2 · Hourmand et al. · 2020 [cited by applicant]
US 10799647B2 · Hosteettler et al. · 2020 [cited by applicant]
US 10881799B2 · Hirschel et al. · 2021 [cited by applicant]
US 10918803B2 · Kemp et al. · 2021 [cited by applicant]
US 11103649B2 · Kemp et al. · 2021 [cited by applicant]
US 11235102B2 · Fenlon · 2022 [cited by examiner]
US 11298462B2 · Atterburg et al. · 2022 [cited by applicant]
US 11383044B2 · Tschirren et al. · 2022 [cited by applicant]
US 11400221B2 · Hourmand et al. · 2022 [cited by applicant]
US 11400222B2 · Hourmand et al. · 2022 [cited by applicant]
US 11400223B2 · Hourmand et al. · 2022 [cited by applicant]
US 11406763B2 · Hourmand et al. · 2022 [cited by applicant]
US 11406764B2 · Hourmand et al. · 2022 [cited by applicant]
US 11452821B2 · Lafever et al. · 2022 [cited by applicant]
US 11511043B2 · Hourmand et al. · 2022 [cited by applicant]
US 12036392B1 · Fenlon et al. · 2024 [cited by applicant]
US 20010005781A1 · Bergens et al. · 2001 [cited by applicant]
US 20010011163A1 · Nolan, Jr. et al. · 2001 [cited by applicant]
US 20020045866A1 · Sadowski et al. · 2002 [cited by applicant]
US 20020083564A1 · James · 2002 [cited by applicant]
US 20030105430A1 · Lavi et al. · 2003 [cited by applicant]
US 20040039336A1 · Amark et al. · 2004 [cited by applicant]
US 20040108339A1 · Hansen et al. · 2004 [cited by applicant]
US 20050020979A1 · Westbye et al. · 2005 [cited by applicant]
US 20050027255A1 · Lavi et al. · 2005 [cited by applicant]
US 20050075602A1 · Cherif-Cheikh et al. · 2005 [cited by applicant]
US 20050075608A1 · Holdgate et al. · 2005 [cited by applicant]
US 20050101919A1 · Brunnberg · 2005 [cited by applicant]
US 20050115507A1 · Halachmi et al. · 2005 [cited by applicant]
US 20050165353A1 · Pessin · 2005 [cited by applicant]
US 20050277896A1 · Messerli et al. · 2005 [cited by applicant]
US 20060036216A1 · Rimlinger et al. · 2006 [cited by applicant]
US 20060151049A1 · Nemoto · 2006 [cited by applicant]
US 20060161114A1 · Perot et al. · 2006 [cited by applicant]
US 20060167412A1 · Marshall · 2006 [cited by applicant]
US 20060184133A1 · Pessin · 2006 [cited by applicant]
US 20070173770A1 · Stamp · 2007 [cited by applicant]
US 20070260348A1 · Gordils · 2007 [cited by applicant]
US 20080147003A1 · Menzi et al. · 2008 [cited by applicant]
US 20080228143A1 · Stamp · 2008 [cited by applicant]
US 20080262427A1 · Hommann · 2008 [cited by applicant]
US 20080269692A1 · James et al. · 2008 [cited by applicant]
US 20090012471A1 · Harrison · 2009 [cited by applicant]
US 20090105663A1 · Brand et al. · 2009 [cited by applicant]
US 20090254027A1 · Moeller · 2009 [cited by applicant]
US 20100152655A1 · Stamp · 2010 [cited by applicant]
US 20100179507A1 · Hess et al. · 2010 [cited by applicant]
US 20100185178A1 · Sharp et al. · 2010 [cited by applicant]
US 20110125100A1 · Schwirtz et al. · 2011 [cited by applicant]
US 20110190693A1 · Takatsuka et al. · 2011 [cited by applicant]
US 20120053528A1 · Bollenbach et al. · 2012 [cited by applicant]
US 20120130321A1 · Woehr · 2012 [cited by applicant]
US 20120186075A1 · Edginton · 2012 [cited by applicant]
US 20120203186A1 · Vogt et al. · 2012 [cited by applicant]
US 20120209092A1 · Alexandersson · 2012 [cited by applicant]
US 20120209192A1 · Alexandersson · 2012 [cited by applicant]
US 20130220869A1 · Klintenstedt et al. · 2013 [cited by applicant]
US 20140243753A1 · Bostrom · 2014 [cited by applicant]
US 20140249479A1 · Pfrang · 2014 [cited by applicant]
US 20140323985A1 · Hourmand et al. · 2014 [cited by applicant]
US 20140330203A1 · McLoughlin et al. · 2014 [cited by applicant]
US 20140330213A1 · Hourmand et al. · 2014 [cited by applicant]
US 20140336590A1 · Hourmand et al. · 2014 [cited by applicant]
US 20140336592A1 · Hourmand et al. · 2014 [cited by applicant]
US 20180064875A1 · Holmqvist · 2018 [cited by applicant]
US 20180140781A1 · Kemp et al. · 2018 [cited by applicant]
US 20180140782A1 · Kemp et al. · 2018 [cited by applicant]
US 20180256822A1 · Hourmand et al. · 2018 [cited by applicant]
US 20190201628A1 · Hourmand et al. · 2019 [cited by applicant]
US 20190201629A1 · Hourmand et al. · 2019 [cited by applicant]
US 20190374717A1 · Swanson et al. · 2019 [cited by applicant]
US 20200405960A1 · Hourmand et al. · 2020 [cited by applicant]
US 20200405961A1 · Hourmand et al. · 2020 [cited by applicant]
US 20210077743A1 · Kemp et al. · 2021 [cited by applicant]
US 20210346604A1 · Hourmand et al. · 2021 [cited by applicant]
US 20220016358A1 · Kemp et al. · 2022 [cited by applicant]
US 20220054755A1 · Hourmand et al. · 2022 [cited by applicant]
US 20220054756A1 · Hourmand et al. · 2022 [cited by applicant]
US 20220054757A1 · Hourmand et al. · 2022 [cited by applicant]
US 20220054758A1 · Hourmand et al. · 2022 [cited by applicant]
US 20240207517A1 · Fenlon et al. · 2024 [cited by applicant]
CA 2212489A1 · 1998 [cited by applicant]
CN 2745588Y · 2005 [cited by applicant]
CN 1911467A · 2007 [cited by applicant]
CN 1977986A · 2007 [cited by applicant]
CN 2925504Y · 2007 [cited by applicant]
CN 101022841A · 2007 [cited by applicant]
CN 101400393A · 2009 [cited by applicant]
CN 101420995A · 2009 [cited by applicant]
CN 201213944Y · 2009 [cited by applicant]
CN 101479004A · 2009 [cited by applicant]
CN 102014993A · 2011 [cited by applicant]
CN 102112168A · 2011 [cited by applicant]
CN 103945879A · 2014 [cited by applicant]
DE 202009009119U1 · 2009 [cited by applicant]
EA 012008B1 · 2009 [cited by applicant]
EA 013934B1 · 2010 [cited by applicant]
EP 0518416A1 · 1992 [cited by applicant]
EP 0692272A1 · 1996 [cited by applicant]
EP 1124601A1 · 2001 [cited by applicant]
EP 1685865A1 · 2006 [cited by applicant]
EP 1702643A2 · 2006 [cited by applicant]
EP 1958654A1 · 2008 [cited by applicant]
EP 2279771A1 · 2011 [cited by applicant]
EP 2438952A1 · 2012 [cited by applicant]
EP 2727617A1 · 2012 [cited by applicant]
EP 2601992A1 · 2013 [cited by applicant]
EP 2777684A1 · 2014 [cited by applicant]
EP 2788052A1 · 2015 [cited by applicant]
EP 3153197A1 · 2017 [cited by applicant]
FR 2764195A1 · 1998 [cited by applicant]
FR 2799654A1 · 2001 [cited by applicant]
GB 407109A · 1934 [cited by applicant]
GB 829724A · 1960 [cited by applicant]
GB 1122592A · 1968 [cited by applicant]
GB 2388033A · 2003 [cited by applicant]
GB 2396298A · 2004 [cited by applicant]
GB 2397767A · 2004 [cited by applicant]
GB 2447339A · 2008 [cited by applicant]
GB 2461084A · 2009 [cited by applicant]
GB 2434317A · 2011 [cited by applicant]
GB 2471473A · 2011 [cited by applicant]
JP H0810324A · 1996 [cited by applicant]
JP 2002503127A · 2002 [cited by applicant]
JP 2002528182A · 2002 [cited by applicant]
JP 2003511159A · 2003 [cited by applicant]
JP 2005021247A · 2005 [cited by applicant]
JP 2005523121A · 2005 [cited by applicant]
JP 2005536300A · 2005 [cited by applicant]
JP 2006507903A · 2006 [cited by applicant]
JP 2006516901A · 2006 [cited by applicant]
JP 2007511299A · 2007 [cited by applicant]
JP 2008500854A · 2008 [cited by applicant]
JP 2009077943A · 2009 [cited by applicant]
JP 2009518080A · 2009 [cited by applicant]
JP 2009523587A · 2009 [cited by applicant]
JP 2009529395A · 2009 [cited by applicant]
JP 2011156005A · 2011 [cited by applicant]
JP 2011524763A · 2011 [cited by applicant]
JP 2014500086A · 2014 [cited by applicant]
JP 2014500089A · 2014 [cited by applicant]
RU 2068708C1 · 1996 [cited by applicant]
RU 2172638C2 · 2001 [cited by applicant]
RU 2311203C2 · 2007 [cited by applicant]
RU 2363500C2 · 2009 [cited by applicant]
RU 2012137269A · 2014 [cited by applicant]
WO WO1998035714A1 · 1998 [cited by applicant]
WO WO1998056442A1 · 1998 [cited by applicant]
WO WO1999010030A2 · 1999 [cited by applicant]
WO WO1999022792A1 · 1999 [cited by applicant]
WO WO2000024441A1 · 2000 [cited by applicant]
WO WO2001008727A1 · 2001 [cited by applicant]
WO WO2001060435A1 · 2001 [cited by applicant]
WO WO2001093926A2 · 2001 [cited by applicant]
WO WO2002047746A1 · 2002 [cited by applicant]
WO WO2003013632A2 · 2003 [cited by applicant]
WO WO2003068297A1 · 2003 [cited by applicant]
WO WO2003090822A1 · 2003 [cited by applicant]
WO WO2003099358A2 · 2003 [cited by applicant]
WO WO2004007006A2 · 2004 [cited by applicant]
WO WO2004020026A1 · 2004 [cited by applicant]
WO WO2004050150A2 · 2004 [cited by applicant]
WO WO2005001161A1 · 2005 [cited by applicant]
WO WO2005002650A1 · 2005 [cited by applicant]
WO WO2005070481A1 · 2005 [cited by applicant]
WO WO2005083614A2 · 2005 [cited by applicant]
WO WO2005115506A1 · 2005 [cited by applicant]
WO WO2005115507A1 · 2005 [cited by applicant]
WO WO2006047810A1 · 2006 [cited by applicant]
WO WO2006085176A1 · 2006 [cited by applicant]
WO WO2006106291A1 · 2006 [cited by applicant]
WO WO2006106295A1 · 2006 [cited by applicant]
WO WO2007056792A1 · 2007 [cited by applicant]
WO WO2007083115A1 · 2007 [cited by applicant]
WO WO2007104636A1 · 2007 [cited by applicant]
WO WO2007129106A2 · 2007 [cited by applicant]
WO WO2008000827A1 · 2008 [cited by applicant]
WO WO2009019437A1 · 2009 [cited by applicant]
WO WO2009022132A2 · 2009 [cited by applicant]
WO WO2009153541A2 · 2009 [cited by applicant]
WO WO2010072644A1 · 2010 [cited by applicant]
WO WO2010097116A1 · 2010 [cited by applicant]
WO WO2010115822A2 · 2010 [cited by applicant]
WO WO2010136076A1 · 2010 [cited by applicant]
WO WO2010136077A1 · 2010 [cited by applicant]
WO WO2010136078A1 · 2010 [cited by applicant]
WO WO2010147553A1 · 2010 [cited by applicant]
WO WO2011000570A1 · 2011 [cited by applicant]
WO WO2011001161A1 · 2011 [cited by applicant]
WO WO2011101378A1 · 2011 [cited by applicant]
WO WO2011109205A2 · 2011 [cited by applicant]
WO WO2012073032A1 · 2012 [cited by applicant]
WO WO2012089445A1 · 2012 [cited by applicant]
WO WO2012164403A2 · 2012 [cited by applicant]
WO WO2013072182A1 · 2013 [cited by applicant]
WO WO2013083613A1 · 2013 [cited by applicant]
WO WO2013083614A1 · 2013 [cited by applicant]
WO WO2014140152A1 · 2014 [cited by applicant]
WO WO2019074788A1 · 2019 [cited by applicant]
WO WO2020190529A1 · 2020 [cited by applicant]
WO WO2021008839A1 · 2021 [cited by applicant]
International Preliminary Report on Patentability in International Appln. No. PCT/EP2014/054922, issued on Sep. 15, 2015, 6 pages. [cited by applicant]
International Search Report and Written Opinion in International Appln. No. PCT/EP2014/054922, mailed on Apr. 1, 2014, 10 pages. [cited by applicant]